Recent Posts

FDA approves Otarmeni as first-ever gene therapy for genetic hearing loss

NEWYou can now listen to Fox News articles! A new therapy for genetic hearing loss has just been approved by the Food and Drug Administration (FDA). The treatment, Otarmeni (lunsotogene parvec-cwha), is the first-ever dual adeno-associated virus (AAV) vector-based gene therapy, meaning it uses two harmless viruses to deliver the …

Read More »
The Ultimate Managed Hosting Platform